Sulodexide improves endothelial dysfunction in streptozotocin-induced diabetes in rats

Physiological Research

Volumn 57, Issue 3, 2008, Pages 491-494

  Kristová, Viera ^a   Liskova S ^a,c   Sotnikova R ^b   Vojtko, R ^a   Kurtansky A ^a  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Acetylcholine induced relaxation; Diabetes; Endothelemia; Endothelial dysfunction; Sulodexide

Indexed keywords

ACETYLCHOLINE; ANTIDIABETIC AGENT; GLYCOSAMINOGLYCAN; SULODEXIDE; VASODILATOR AGENT;

ANIMAL; ARTICLE; DIABETIC ANGIOPATHY; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; MALE; PATHOPHYSIOLOGY; RAT; TIME; VASCULAR ENDOTHELIUM; VASODILATATION; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GLYCOSAMINOGLYCANS; HYPOGLYCEMIC AGENTS; MALE; RATS; RATS, WISTAR; TIME FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 45849133109     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 4 administration. Physiol Res 55: 245-251, 2006.
2. DIGNAT-GEORGE F, SAMPOL J, LIP G et al: Circulating endothelial cells: realities and promises in vascular disorders. Pathophysiol Haemost Thromb 33: 495-499, 2003/2004.
3. GADDI A, GALETTI C, ILLUMINATI B, NASCETTI S: Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease. J Int Med Res 24: 389-406, 1996.
4. HLADOVEC J, ROSSMANN P: Circulating endothelial cells isolated together with platelets and the experimental modification of their counts in rats. Thromb Res 3: 665-668, 1973.
5. KOJŠOVÁ S, JENDEKOVÁ L, ZICHA J, KUNEŠ J, ANDRIANTSITOHAINA R, PECHÁŇOVÁ O: The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol Res 55: S3-S16, 2006.
6. KRISTOVÁ V, KRIŠKA M: Endothelial diseases and endothelium protective substances. Bratisl Lek Listy 99: 511-517, 1998.
7. KRISTOVÁ V, KRIŠKA M, BABÁL P, DJIBRIL MN, SLÁMOVÁ J, KURTANSKÝ A: Evaluation of endothelium- protective effects of drugs in experimental models of endothelial damage. Physiol Res 49: 123-128, 2000.
8. KRISTOVÁ V, KISS A, PIRNIK Z, KRIŠKA M, JEŽOVÁ D: Effect of pentoxifylline on endothelaemia and hypothalamic-pituitary-adrenocortical axis activation in female rats under stress exposure. Gen Physiol Biophys 25: 81-86, 2006.
9. rd: Diabetes, oxidative stress and antioxidants: a review. J Biochem Mol Toxicol 17: 153-158, 2003.
10. PECHÁŇOVÁ O, ŠIMKO F: The role of nitric oxide in the maintenance of vasoactive balance. Physiol Res 56: S7-S16, 2007.
11. RAJEC J, TISOŇOVÁ J, KRIŠKA M, KRISTOVÁ V, VOJTKO R, DUKÁT A, AMBRÓZY E, SLYŠKO R, VARGA I: Endothelaemia-a marker of vascular damage. Bratisl Lek Listy 109: 403-405, 2007.
12. YKI-JÄRVINEN: Management of type 2 diabetes mellitus and cardiovascular risk. Drugs 60: 975-983, 2000.
13. ZUROVÁ-NEDELČEVOVÁ J, NAVAROVÁ J, DRÁBIKOVÁ K, JANČINOVÁ V, PETRÍKOVÁ M, BERNÁTOVÁ I, KRISTOVÁ V, ŠNIRC V, NOSÁL'OVÁ V, SOTNÍKOVÁ R: Participation of reactive oxygen species in diabetes-induced endothelial dysfunction. Neuroendocrinol Lett 27: 168-171, 2006.